Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
of Medicine, University of Oxford, Oxford, UK
Phase 2 trial data (NCT04881760) reported diarrhoea in approximately 2030% of participants at higher doses, with symptoms most pronounced during dose-escalation phases
The characterization of this compound is performed solely through rigorous physicochemical testing and controlled laboratory-based research protocols
J.DeesA
Topical formulations are designed for localized application and are being researched for skin, soft tissue, and musculoskeletal support
Costell M et al
US$ 26.68
US$ 29.85
US$ 25.62
US$ 20.02
US$ 22.65
US$ 28.88
US$ 24.62
US$ 21.89
US$ 23.74
US$ 27.44
